We are seeking an experienced marketer to support the development of the patient and APP strategy and tactics for the CELMoDs portfolio in multiple myeloma. This includes leading patient- and APP-focused work initiatives in market research, patient insight development, messaging, promotional asset development, and media management, considering all current and future indications for two products: iberdomide and mezigdomide. This role offers the opportunity to shape the future of oncology patient marketing and APP engagement for the CELMoDs portfolio, directly impacting patient outcomes and advancing our mission to improve the lives of those affected by multiple myeloma.